LFSTLifeStance Health Group, Inc.

Nasdaq lifestance.com


$ 5.70 $ 0.02 (0.44 %)    

Friday, 09-Aug-2024 13:31:21 EDT
QQQ $ 451.74 $ 5.97 (1.34 %)
DIA $ 396.09 $ 2.54 (0.65 %)
SPY $ 534.21 $ 5.58 (1.06 %)
TLT $ 96.21 $ 0.06 (0.07 %)
GLD $ 225.01 $ 0.18 (0.08 %)
$ 5.93
$ 5.68
$ 5.68 x 600
$ 5.69 x 500
$ 5.57 - $ 5.82
$ 4.64 - $ 9.20
3,495,865
na
2.25B
$ 1.51
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-09-2024 03-31-2024 10-Q
3 02-28-2024 12-31-2023 10-K
4 11-08-2023 09-30-2023 10-Q
5 08-09-2023 06-30-2023 10-Q
6 05-10-2023 03-31-2023 10-Q
7 03-09-2023 12-31-2022 10-K
8 11-09-2022 09-30-2022 10-Q
9 08-10-2022 06-30-2022 10-Q
10 05-11-2022 03-31-2022 10-Q
11 03-17-2022 12-31-2021 10-K
12 11-10-2021 09-30-2021 10-Q
13 08-12-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 barclays-maintains-underweight-on-lifestance-health-gr-lowers-price-target-to-6

Barclays analyst Stephanie Davis maintains LifeStance Health Gr (NASDAQ:LFST) with a Underweight and lowers the price target...

 lifestance-health-expects-q3-revenue-of-290m-310m-vs-301898m-est

2024 Guidance LifeStance is providing the following outlook for 2024: The Company is raising full year revenue to $1.2 bill...

 lifestance-health-expects-2024-revenue-of-12b-1242b-prior-119b-124b-vs-122b-est-sees-adjusted-ebitda-of-90m-100m

2024 Guidance LifeStance is providing the following outlook for 2024: The Company is raising full year revenue to $1.2 bill...

 lifestance-health-gr-q2-2024-gaap-eps-006-beats-007-estimate-sales-312331m-beat-307565m-estimate

LifeStance Health Gr (NASDAQ:LFST) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of ...

 lifeist-shrinks-net-loss-49-yoy-drop-in-q2-net-revenue-plans-move-away-from-its-legacy-cannabis-business

Lifeist Wellness Inc. (TSXV: LFST) (FRANKFURT: M5B0) (OTCMKTS: LFSWF), a health-tech company reported on Tuesday its financial ...

 executive-changes-in-cannabis-industry-you-should-know-about-new-appointments--more

Shareholders of four cannabis companies held their respective annual meetings, electing nominees as board directors.Sandy Li, w...

 simply-solventless-to-acquire-cannmart-as-it-seeks-to-expand-into-hydrocarbon-cannabis-concentrates

Simply Solventless Concentrates Ltd. (TSXV: HASH) is acquiring Lifeist Wellness Inc.'s (TSXV: LFST) (FRANKFURT: M5B) (OTCMK...

 global-weed-business-flora-buys-australian-vaporizers-as-im-cannabis-doubles-down-on-germany

Lifeist Wellness Inc. (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF) said on Wednesday the sale of Australian Vaporizers Pty Lt...

 why-lifestance-health-group-lsft-stock-is-falling

LifeStance Health shares are trading lower by 19.8% during Wednesday's session. The company announced pricing of a 20 milli...

 reported-earlier-lifestance-health-group-prices-secondary-public-offering-of-20m-common-shares-at-625share

The Selling Stockholders will receive all of the proceeds from the offering. The Company is not selling any shares of Common St...

 lifestance-health-reiterated-fy24-revenue-of-119b-124b-vs-122b-est

2024 Guidance LifeStance is providing the following outlook for 2024: The Company is reiterating full year revenue of $1.19...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION